Open position for a PhD position in EU Horizon 2020 SINERGIA Project.
MTTlab has started the selection process for an early-stage researcher (ESR) PhD position in the EU Horizon 2020 Marie-Skłodowska-Curie Project: MSCA-ITN-ETN SINERGIA. This project has received funding from the European[…]Read more
MTTlab at EUSAAT, Linz 10/10 – 13/10, 2019
MTTlab at 19th Annual Congress of EUSAAT, Linz 10/10 – 13/10, 2019: MTTlab Srl will be present at the 19th Annual Congress of EUSAAT (22nd European Congress on Alternatives to[…]Read more
MTTlab and BIOTOXIK – new collaboration
MTTlab and BIOTOXIK have entered into a new collaboration to expand your research using the best technologies. Please visit our Collaborations section.Read more
MTTlab offers toxicological in-vitro programs for pharmaceutical compounds and in-vivo preclinical research and development services in the field of oncology, behavioural and inflammation studies.
Expand your research possibilities with MTTlab
MTTlab is a preclinical CRO (Contract Research Organization) providing biomedical, biotechnological and pharmaceutical testing services for biotech industry. MTTlab specializes in early research and proof-of-principle pharmacology studies in rodent models. MTTlab team recognizes the clients need for timely delivery of accurate and accessible data in order to support critical decisions affecting the progress of your research/technology. MTTlab services are available worldwide for private companies, academic institutions and government research centers.Read More
Request more information using the form below.